The anabolic-androgenic steroid nandrolone induces alterations in the density of serotonergic 5HT1B and 5HT2 receptors in the male rat brain

Neuroscience

Volumn 119, Issue 1, 2003, Pages 113-120

  Kindlundh, A M S ^a   Lindblom, J ^b   Bergstrom L ^b   Nyberg, F ^a  

^a Div Biol Res Drug Dependence   (Sweden)

^b Division of Pharmacology   (Sweden)

Author keywords

Aggression; Autoradiography; Rat brain; Serotonin receptors; 125I ( ) DOI; 125I ( ) iodocyanopindolol

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; IODINE 125; NANDROLONE DECANOATE; RADIOLIGAND; SEROTONIN 1B RECEPTOR; SEROTONIN 2 RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; GLOBUS PALLIDUS; HIPPOCAMPUS; HYPOPHYSIS INTERMEDIATE LOBE; LIGAND BINDING; MALE; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; ZONA INCERTA;

EID: 0037649989     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00120-9     Document Type: Article

References (66)

1. Ait Amara D., Segu L., Naili S., Buhot M.C. Serotonin 1B receptor regulation after dorsal subiculum deafferentation. Brain Res Bull. 38:1995;17-23.
2. Appel N.M., Mitchell W.M., Garlick R.K., Glennon R.A., Teitler M., De Souza E.B. Autoradiographic characterization of (±)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain. J Pharmacol Exp Ther. 255:1990;843-857.
3. Archer J. The influence of testosterone on human aggression. Br J Psychol. 82:(pt 1):1991;1-28.
4. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol. 179:1978;641-667.
5. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
6. Berridge K.C., Robinson T.E. What is the role of dopamine in reward hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 28:1998;309-369.
7. Bonson K.R., Johnson R.G., Fiorella D., Rabin R.A., Winter J.C. Serotonergic control of androgen-induced dominance. Pharmacol Biochem Behav. 49:1994;313-322.
8. Choi P.Y., Pope H.G. Jr. Violence toward women and illicit androgenic-anabolic steroid use. Ann Clin Psychiatry. 6:1994;21-25.
9. Coccaro E.F. Impulsive aggression a behavior in search of clinical definition . Harv Rev Psychiatry. 5:1998;336-339.
10. De Deurwaerdere P., Spampinato U. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem. 73:1999;1033-1042.
11. Di Chiara G. Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol. 375:1999;13-30.
12. Di Chiara G., Tanda G., Bassareo V., Pontieri F., Acquas E., Fenu S., Cadoni C., Carboni E. Drug addiction as a disorder of associative learning role of nucleus accumbens shell/extended amygdala dopamine . Ann NY Acad Sci. 877:1999;461-485.
13. Di Matteo V., Di Giovanni G., Di Mascio M., Esposito E. Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology. 37:1998;265-272.
14. Di Matteo V., De Blasi A., Di Giulio C., Esposito E. Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci. 22:2001;229-232.
15. Dolan M., Anderson I.M., Deakin J.F. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. Br J Psychiatry. 178:2001;352-359.
16. DuRant R.H., Escobedo L.G., Heath G.W. Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics. 96:1995;23-28.
17. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., Robbins T.W. Associative processes in addiction and reward the role of amygdala-ventral striatal subsystems . Ann NY Acad Sci. 877:1999;412-438.
18. Feldman S., Newman M.E., Gur E., Weidenfeld J. Role of serotonin in the amygdala in hypothalamo-pituitary-adrenocortical responses. Neuroreport. 9:1998;2007-2009.
19. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr, Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
20. Gobert A., Rivet J.M., Lejeune F., Newman-Tancredi A., Adhumeau-Auclair A., Nicolas J.P., Cistarelli L., Melon C., Millan M.J. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways a combined dialysis and electrophysiological analysis in the rat . Synapse. 36:2000;205-221.
21. Hallberg M., Johansson P., Kindlundh A.M., Nyberg F. Anabolic-androgenic steroids affect the content of substance P and substance P(1-7) in the rat brain. Peptides. 21:2000;845-852.
22. Herve D., Pickel V.M., Joh T.H., Beaudet A. Serotonin axon terminals in the ventral tegmental area of the rat fine structure and synaptic input to dopaminergic neurons . Brain Res. 435:1987;71-83.
23. Insel T.R. Obsessive-compulsive disorder. Psychiatr Clin North Am. 8:1985;105-117.
24. Johansson P., Hallberg M., Kindlundh A., Nyberg F. The effect on opioid peptides in the rat brain, after chronic treatment with the anabolic androgenic steroid, nandrolone decanoate. Brain Res Bull. 51:2000;413-418.
25. Johansson P., Lindqvist A., Nyberg F., Fahlke C. Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. Pharmacol Biochem Behav. 67:2000;271-279.
26. Johansson-Steensland P., Nyberg F., Chahl L. The anabolic androgenic steroid, nandrolone decanoate, increases the density of Fos-like immunoreactive neurons in limbic regions of guinea-pig brain. Eur J Neurosci. 15:2002;539-544.
27. Jänne O.A. Androgen interaction through multiple steroid receptors. Lin G., Erinoff L. Anabolic steroid abuse National Institute of Drug Abuse research monograph series . 1990;178-186 US Department of Health and Human Services, Rockville.
28. Kindlundh A., Lindblom J., Bergstrom L., Wikberg J., Nyberg F. The anabolic-androgenic steroid nandrolone decanoate affects the density of dopamine receptors in the male rat brain. Eur J Neurosci. 13:2001;291-296.
29. Kindlundh A.M., Isacson D.G., Berglund L., Nyberg F. Doping among high school students in Uppsala, Sweden a presentation of the attitudes, distribution, side effects, and extent of use . Scand J Soc Med. 26:1998;71-74.
30. Kindlundh A.M., Isacson D.G., Berglund L., Nyberg F. Factors associated with adolescent use of doping agents anabolic-androgenic steroids . Addiction. 94:1999;543-553.
31. Kindlundh A.M., Hagekull B., Isacson D.G., Nyberg F. Adolescent use of anabolic-androgenic steroids and relations to self-reports of social, personality and health aspects. Eur J Public Health. 11:2001;322-328.
32. Koob G.F. Drugs of abuse anatomy, pharmacology and function of reward pathways . Trends Pharmacol Sci. 13:1992;177-184.
33. Laviano A., Cangiano C., Preziosa I., Meguid M.M., Muscaritoli M., Conversano L., Cascino A., Torelli G.F., Cherubini S., Fanelli F.R. Serotoninergic block in the ventromedial nucleus of hypothalamus improves food intake in anorectic tumor bearing rats. Adv Exp Med Biol. 398:1996;551-553.
34. Le Greves P., Huang W., Johansson P., Thornwall M., Zhou Q., Nyberg F. Effects of an anabolic-androgenic steroid on the regulation of the NMDA receptor NR1, NR2A and NR2B subunit mRNAs in brain regions of the male rat. Neurosci Lett. 226:1997;61-64.
35. Lindqvist A.-S., Johansson-Steensland P., Nyberg F., Fahlke C. Anabolic androgenic steroid affects competitive behaviour, behavioural response to ethanol and brain serotonin levels. Behav Brain Res. 133:2002;21-29.
36. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., Wihler C., Koliatsos V.E., Tessarollo L. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA. 96:1999;15239-15244.
37. McBride P.A., Anderson G.M., Hertzig M.E., Sweeney J.A., Kream J., Cohen D.J., Mann J.J. Serotonergic responsivity in male young adults with autistic disorder results of a pilot study . Arch Gen Psychiatry. 46:1989;213-221.
38. Moukhles H., Bosler O., Bolam J.P., Vallee A., Umbriaco D., Geffard M., Doucet G. Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience. 76:1997;1159-1171.
39. Oreland L. Monoamine oxidase in neuro-pscychiatric disorders. Yasuhara H., Parvez S.H., Oguchi K., Sandler M., Nagatsu T. Monoamine oxidase basic and clinical aspects . 1993;219-247 VSP Press, Utrecht.
40. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 3rd edition:1997;Academic Press, Inc, San Diego.
41. Pazos A., Engel G., Palacios J.M. beta-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain. Brain Res. 343:1985;403-408.
42. Pittenger C., Kandel E. A genetic switch for long-term memory. C R Acad Sci III. 321:1998;91-96.
43. Pope H.G. Jr, Katz D.L. Homicide and near-homicide by anabolic steroid users. J Clin Psychiatry. 51:1990;28-31.
44. Pope H.G. Jr, Katz D.L., Hudson J.I. Anorexia nervosa and "reverse anorexia" among 108 male bodybuilders. Compr Psychiatry. 34:1993;406-409.
45. Porcerelli J.H., Sandler B.A. Narcissism and empathy in steroid users. Am J Psychiatry. 152:1995;1672-1674.
46. Redish A.D., Touretzky D.S. Cognitive maps beyond the hippocampus. Hippocampus. 7:1997;15-35.
47. Rosenberg P.B., Rosse R.B., Schwartz B.L., Deutsch S.I. Nefazodone in the adjunctive therapy of schizophrenia an open-label exploratory study . Clin Neuropharmacol. 23:2000;222-225.
48. Sari Y., Miquel M.C., Brisorgueil M.J., Ruiz G., Doucet E., Hamon M., Verge D. Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system immunocytochemical, autoradiographic and lesion studies . Neuroscience. 88:1999;899-915.
49. Sasaki-Adams D.M., Kelley A.E. Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior. Neuropsychopharmacology. 25:2001;440-452.
50. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., Buhot M.C., Hen R. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science. 265:1994;1875-1878.
51. Sedvall G., Fyro B., Gullberg B., Nyback H., Wiesel F.A., Wode-Helgodt B. Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Br J Psychiatry. 136:1980;366-374.
52. Siegel A., Roeling T.A., Gregg T.R., Kruk M.R. Neuropharmacology of brain-stimulation-evoked aggression. Neurosci Biobehav Rev. 23:1999;359-389.
53. Simon N.G., Cologer-Clifford A., Lu S.F., McKenna S.E., Hu S. Testosterone and its metabolites modulate 5HT1A and 5HT1B agonist effects on intermale aggression. Neurosci Biobehav Rev. 23:1998;325-336.
54. Smith S.T., Stackman R.W., Clark A.S. Spatial working memory is preserved in rats treated with anabolic-androgenic steroids. Brain Res. 737:1996;313-316.
55. Spanagel R., Weiss F. The dopamine hypothesis of reward past and current status . Trends Neurosci. 22:1999;521-527.
56. Sprouse J.S., Aghajanian G.K. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists a comparative study with dorsal raphe neurons . Neuropharmacology. 27:1988;707-715.
57. Su T.-P., Pagliaro M., Schmidt P.J., Pickar D., Wolkowitz O., Rubinow D.R. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 269:1993;2760-2764.
58. Summers C.H. Mechanisms for quick and variable responses. Brain Behav Evol. 57:2001;283-292.
59. Summers C.H., Larson E.T., Ronan P.J., Hofmann P.M., Emerson A.J., Renner K.J. Serotonergic responses to corticosterone and testosterone in the limbic system. Gen Comp Endocrinol. 117:2000;151-159.
60. Tanner S.M., Miller D.W., Alongi C. Anabolic steroid use by adolescents prevalence, motives, and knowledge of risks . Clin J Sport Med. 5:1995;108-115.
61. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 374:1995;542-546.
62. Thiblin I., Kristiansson M., Rajs J. Anabolic androgenic steroids and behavioural patterns among violent offenders. J Forensic Psych. 8:1997;299-310.
63. Thiblin I., Runeson B., Rajs J. Anabolic androgenic steroids and suicide. Ann Clin Psychiatry. 11:1999;223-231.
64. Thiblin I., Finn A., Ross S.B., Stenfors C. Increased dopaminergic and 5-hydroxytryptaminergic activities in male rat brain following long-term treatment with anabolic androgenic steroids. Br J Pharmacol. 126:1999;1301-1306.
65. Yates W.R., Perry P., Murray S. Aggression and hostility in anabolic steroid users. Biol Psychiatry. 31:1992;1232-1234.
66. Zuckerman M. P-impulsive sensation seeking and its behavioral, psychophysiological and biochemical correlates. Neuropsychobiology. 28:1993;30-36.